Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 33.50
-0.45 (-1.33%)
Aug 15, 2025, 1:57 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.46 billion as of August 15, 2025. Its market cap has decreased by -13.53% in one year.
Market Cap
1.46B
Enterprise Value
972.58M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.50
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has decreased from 1.48B to 1.46B, a decrease of -0.97%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 1.46B | -1.32% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 165.97B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.66B |
| Oneness Biotech | 32.23B |
| Polaris Group | 27.47B |
| Lumosa Therapeutics | 27.18B |
| Center Laboratories | 26.42B |